FIH Study of the GEMINUS TAVI System in Patients With Severe Symptomatic Aortic Stenosis - Trial NCT05909748
Access comprehensive clinical trial information for NCT05909748 through Pure Global AI's free database. This phase not specified trial is sponsored by Valve Medical and is currently Recruiting. The study focuses on Aortic Valve Stenosis. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Valve Medical
Timeline & Enrollment
N/A
May 21, 2023
Apr 01, 2030
Primary Outcome
Technical success (at exit from procedure room)
Summary
The main objective of this study is to evaluate the feasibility and safety of the GEMINUS
 system in patients with severe symptomatic aortic stenosis.
 
 This is a prospective, open label, multicentre, single arm, first in human clinical study.
 
 Clinical follow up for all patients will be performed at 30 days, 6 months, 1, 2, 3, 4 and 5
 years post-implantation
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05909748
Device Trial